Genocea Biosciences (GNCA) Misses Q1 EPS by 5c

Genocea Biosciences (NASDAQ: GNCA) reported Q1 EPS of ($0.64), $0.05 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $121 thousand versus the consensus estimate of $60 thousand.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
• Traws Pharma (TRAW) Tops Q2 EPS by 27c